Bladder cancer (BC) refers to any of several types of cancer that arises from the tissues of the urinary bladder. From:Neoplasia,2022 About this page Set alert Chapters and Articles You might find these chapters and articles relevant to this topic. ...
Bellmunt J,Orsola A,WiegelT,et al.Bladder cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2011,22(Suppl6):vi45-49.Bellmunt J, Orsola A, Wiegel T, et al. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and fol- low-...
The treatment landscape for bladder cancer is guided by comprehensive recommendations from leading institutions like the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO). The NCCN 2024 guidelines recommend neoadjuvant chemotherapy with ddMVAC and growth factor...
Muscle-invasive bladder cancer (MIBC) is a highly aggressive disease with a poor prognosis. B cells are crucial factors in tumor suppression, and tertiary lymphoid structures (TLSs) facilitate immune cell recruitment to the tumor microenvironment (TME).
Non-muscle invasive bladder cancer (NMIBC) is a major type of bladder cancer with a high incidence worldwide, resulting in a great disease burden. Treatment and surveillance are the most important part of NIMBC management. In 2018, we issued “Treatment
Bladder cancer has a high recurrence rate which requires frequent follow-up. Cystoscopy is currently the gold standard for follow-up which is invasive and undesirable procedure for patients. We aimed to investigate the feasibility of noninvasive studies
Publication » 7 Non-muscle-invasive Bladder Cancer GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER. M Babjuk,W Oosterlinck,R Sylvester,... 被引量: 3发表: 2022年 LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pa...
Shed cells contain alpha1-oleate, treated tumors show evidence of apoptosis and the expression of cancer-related genes is inhibited (secondary endpoints). The results are especially encouraging for bladder cancer, where therapeutic failures and high recurrence rates create a great, unmet medical need....
Nuclear Oncology, Springer, Cham (2022) in press Google Scholar 4 Cancer EGM-iaMB. EAU: Guidelines muscle-invasive and metastatic bladder cancer. 2021. [Available at: https://uroweb.org. Accessed November 25, 2021. Google Scholar 5 HB Grossman, RB Natale, CM Tangen, et al. Neoadjuvant che...
Tracy L. Rose, MD, MPH Disclosures June 14, 2022 0Tracy Rose, MD, enthusiastically discusses three presentations on recent bladder cancer research at ASCO 2022. The first, on the QUILT 3.032 trial, offered results with the combined therapeutic agents bacille Calmette-Guérin (BCG) and the ...